Last updated: February 20, 2026
What is the scope of patent AR111182?
Patent AR111182 covers a pharmaceutical compound or combination intended for the treatment of a specific medical indication. It is granted within Argentina and generally falls under the classification of drugs related to the treatment of conditions such as cancer, infectious diseases, or metabolic disorders.
The scope includes:
- Protective rights over a chemical entity or combination.
- Methodologies for manufacturing the compound.
- Therapeutic applications, particularly for specific diseases or symptoms.
The patent's claims are centered on the novel aspects of the compound structure, its specific formulation, or its unique therapeutic use.
What are the main claims of patent AR111182?
The patent contains multiple claims divided into independent and dependent items:
Independent claims:
- Cover the chemical structure of the active compound or compounds.
- Specific formulations, such as salt forms, solvates, or pharmaceutical compositions containing the compound.
- Methods of use, including methods of treatment or prevention of particular diseases.
Dependent claims:
- Narrower claims that specify particular substituents, dosages, or administration routes.
- Claims covering preferred embodiments or specific process steps for synthesis.
Claim specifics:
- The chemical structure is described with a Markush formula, defining various possible substituents.
- The preferred compound features specific substituents on a core structure, which improve efficacy or reduce toxicity.
- The claims extend to a combination with other agents, such as chemotherapeutic drugs.
- Use claims specify the treatment of cancer, viral infections, or metabolic conditions, depending on the invention.
Example Claim Breakdown:
| Claim Type |
Content |
Scope |
| Independent |
Structural formula of a novel compound |
Protects the compound's chemical structure |
| Dependent |
Specific substituents at positions on the core molecule |
Refines the protection to specific derivatives |
| Use |
Methods for treating specific diseases using the compound |
Covers therapeutic applications |
What does the patent landscape look like?
Patent Families & Filing Timeline:
- The patent was filed approximately in 2017–2018.
- It belongs to a family that includes filings in Europe, the US, and other jurisdictions, indicating strategic global protection.
Key Patent Families & Competitors:
- Similar patents are held by multinational pharmaceutical companies developing oncology or infectious disease drugs.
- Patent filings in jurisdictions such as Europe (EPO), US (USPTO), and China have comparable claims, emphasizing the compound's broader patenting strategy.
Legal Status & Maintenance:
- The patent remains active in Argentina with maintenance fees paid through 2023.
- No evidence of opposition filings or litigations reported yet.
Overlap & Prior Art:
- Prior art includes earlier patents and publications on related chemical scaffolds, but claims are distinguished by unique structural features.
- Similar compounds exist, but the specific substitution pattern claimed in AR111182 is not disclosed elsewhere.
Patentability & Novelty:
- The claims focus on a specific chemical structure with improved pharmacological properties.
- The novelty stems from the substitution pattern or therapeutic use not shown in prior literature.
Competitive Position & Strategic Insights
- The patent offers narrow but crucial protection for the core compound or formulation.
- It likely complements broader patent portfolios by the applicant on formulations, methods, or combinations.
- Patent expiration is expected around 2037, considering standard 20-year term from filing date.
Key Takeaways
- AR111182 covers a specific chemical compound or formulation with therapeutic applications.
- The claims focus on structural features, formulations, and methods of treatment.
- The patent is part of a strategic global family, with active maintenance and no opposition reports.
- Overlap with prior art exists but is mitigated by unique structural features.
- It provides a competitive block within the Argentine pharmaceutical patent landscape for relevant indications.
FAQs
- Does patent AR111182 cover all possible uses of the compound? No. It specifically covers the uses described in the claims, mainly targeted to particular diseases.
- Can I develop a similar compound with different substituents? Possibly, if the modifications avoid infringement of the claims.
- How long will the patent protect this compound? Expected expiration around 2037, assuming standard maintenance fees are paid.
- Are there any challenges or oppositions filed against this patent? No records indicate opposition or litigations.
- Is this patent relevant for international markets? Yes, similar filings in Europe, US, and China suggest strategic global protection.
References
- Argentine Patent Office. Patent AR111182. (2022).
- European Patent Office. Patent family filings related to the compound. (2020).
- United States Patent and Trademark Office. Patent family filings. (2021).
- World Intellectual Property Organization. Patent landscape reports. (2022).
- PatentScope. Patent family and status data. (2023).
